Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Astellas Pharma Inc (Astellas) discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The companys product portfolio comprises marketed products for the treatment of a wide range of urological diseases, infectious diseases, cancer, nephrology, and metabolic diseases, immunodeficiency diseases, and transplantation. It is investigating its pipeline encompasses candidates for the treatment of urothelial cancer; gastric cancer; gastroesophageal junction cancer; anemia associated with chronic kidney disease (CKD) in dialysis and non-dialysis patients; menopause-related vasomotor symptoms (MR-VMS) such as hot flashes and night sweats; and acute myeloid leukemia (AML), among others. It operates in the Americas; Europe; and Asia and Oceania through its network of subsidiaries and affiliates. Astellas is headquartered in Tokyo, Japan.

Astellas Pharma Inc Key Recent Developments

Jun 16,2020: Astellas efforts against the spread of the Coronavirus Disease (COVID-19)
Jun 05,2020: Astellas, City of Yokohama, and Yokohama City University developed science-based exercise programs through industry-government-academia collaboration
May 27,2020: Astellas efforts against the spread of the Coronavirus disease
May 13,2020: Astellas efforts against the spread of the Coronavirus Disease (COVID-19)
Apr 30,2020: Astellas Pharma support solutions help to address evolving patient needs during COVID-19

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company
Astellas Pharma Inc - Key Facts
Astellas Pharma Inc - Key Employees
Astellas Pharma Inc - Key Employee Biographies
Astellas Pharma Inc - Major Products and Services
Astellas Pharma Inc - History
Astellas Pharma Inc - Company Statement
Astellas Pharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 Company Analysis
Company Overview
Astellas Pharma Inc - Business Description
Product Category: Betanis/Myrbetriq/BETMIGA
Performance
Product Category: Other Products
Performance
Key Stats
Product Category: Prograf
Performance
Product Category: Vesicare
Performance
Product Category: Xtandi
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Others
Performance
Geographical Segment: United States
Performance
R&D Overview
Astellas Pharma Inc - Corporate Strategy
Astellas Pharma Inc - SWOT Analysis
SWOT Analysis - Overview
Astellas Pharma Inc - Strengths
Astellas Pharma Inc - Weaknesses
Astellas Pharma Inc - Opportunities
Astellas Pharma Inc - Threats
Astellas Pharma Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Astellas Pharma Inc, Recent Deals Summary
Section 5 Companys Recent Developments
Jun 16, 2020: Astellas efforts against the spread of the Coronavirus Disease (COVID-19)
Jun 05, 2020: Astellas, City of Yokohama, and Yokohama City University developed science-based exercise programs through industry-government-academia collaboration
May 27, 2020: Astellas efforts against the spread of the Coronavirus disease
May 13, 2020: Astellas efforts against the spread of the Coronavirus Disease (COVID-19)
Apr 30, 2020: Astellas Pharma support solutions help to address evolving patient needs during COVID-19
Apr 28, 2020: Astellas efforts against the spread of the Coronavirus Disease (COVID-19)
Apr 28, 2020: Astellas and Harvard establish strategic research alliance
Apr 27, 2020: Astellas Pharma: Change of Directors and Organizational Change
Apr 27, 2020: Harvard and Astellas establish Strategic Research Alliance
Apr 06, 2020: Three Astellas Research and Production facilities in Japan Adopt Aqua Premium
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Astellas Pharma Inc, Key Facts
Astellas Pharma Inc, Key Employees
Astellas Pharma Inc, Key Employee Biographies
Astellas Pharma Inc, Major Products and Services
Astellas Pharma Inc, History
Astellas Pharma Inc, Other Locations
Astellas Pharma Inc, Subsidiaries
Astellas Pharma Inc, Joint Venture
Astellas Pharma Inc, Key Competitors
Astellas Pharma Inc, Ratios based on current share price
Astellas Pharma Inc, Annual Ratios
Astellas Pharma Inc, Annual Ratios (Cont...1)
Astellas Pharma Inc, Annual Ratios (Cont...2)
Astellas Pharma Inc, Interim Ratios
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Astellas Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Astellas Pharma Inc, Performance Chart (2016 - 2020)
Astellas Pharma Inc, Ratio Charts
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Astellas Pharma Inc Strategic Analysis Review- Astellas Pharma Inc SWOT, Outlook, Operations and Financial Profile

Astellas Pharma Inc Company Profile provides strategic analysis of Astellas Pharma Inc Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200 View Report

Ocuphire Pharma Inc (OCUP) - Financial and Strategic SWOT Analysis Review

Ocuphire Pharma Inc (Ocuphire Pharma), formerly Rexahn Pharmaceuticals Inc, is an ophthalmic biopharmaceutical company that develops and commercializes medicines to treat eye disorders. It is investigating Nyxol, a preservative-free ophthalmic

USD 300 View Report

PDL BioPharma Inc - Strategic SWOT Analysis Review

PDL BioPharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available